SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015041
Filing Date
2021-11-08
Accepted
2021-11-08 16:18:07
Documents
79
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cara-20210930x10q.htm   iXBRL 10-Q 2816832
2 EX-10.1 cara-20210930xex10d1.htm EX-10.1 287459
3 EX-31.1 cara-20210930xex31d1.htm EX-31.1 12114
4 EX-31.2 cara-20210930xex31d2.htm EX-31.2 11787
5 EX-32.1 cara-20210930xex32d1.htm EX-32.1 10168
  Complete submission text file 0001558370-21-015041.txt   10692400

Data Files

Seq Description Document Type Size
6 EX-101.SCH cara-20210930.xsd EX-101.SCH 59535
7 EX-101.CAL cara-20210930_cal.xml EX-101.CAL 60389
8 EX-101.DEF cara-20210930_def.xml EX-101.DEF 297018
9 EX-101.LAB cara-20210930_lab.xml EX-101.LAB 547668
10 EX-101.PRE cara-20210930_pre.xml EX-101.PRE 478899
11 EXTRACTED XBRL INSTANCE DOCUMENT cara-20210930x10q_htm.xml XML 1922749
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 211388209
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences